Drugs research

B. Testa, G. Cruciani, Structure-metabolism relations and the challenge of predicting biotransformation, in Pharmacokinetic Optimization in Drug Research, B. Testa, H. van de Water-beemd, G. Folkers, R. Guy (Eds.), WHey-VCH, Weinheim, New York, 2001, pp. 65-84. [Pg.620]

L. B. Kier, L. H. Hall, Molecular Cxmnectivity in Chemistry and Drug Research Academic Press, San Diego (1976). [Pg.250]

C. R. GaneUin and S. M. Roberts, eds.. Medicinal Chemisty, The Role of Organic Chemisty in Drug Research 2nd ed.. Academic Press, Inc., San Diego, Calif., 1993. [Pg.264]

E. De Qercq, in V. Qaassen, ed.. Trends in Drug Research, Elsevier Science PubUshers, Amsterdam, The Netherlands, 1990, p. 133. [Pg.317]

Heterocyclization under Vilsmeier conditions and its possibilities in drug research 95E439. [Pg.216]

Furchgott, R. F. (1966). The use of P-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In Advances in drug research, edited by N. J. Harper, A. B. Simmonds, Vol. 3, pp. 21-55. Academic Press, London, New York. [Pg.98]

Kubinyi, H. (2003). Drug research Myths, hype, and reality. Nature Rev. Drug Disc. 2 665-668. [Pg.197]

Kenakin, T. P. (1985). Drug and organ selectivity Similarities and differences. In Advances in drug research, Vol. 15, edited by B. Test, pp. 71-109. Academic Press, New York. [Pg.197]

Combinatorial chemistry constitutes a branch of the molecular sciences, providing an array of concepts and methods to solve molecular optimization problems (in drug research and beyond) more rapidly and efficiently than classical synthetic approaches. [Pg.381]

Munich Center for Integrated Protein Science CiPSM and Department of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universitat Munchen, 81377 Munchen, Germany... [Pg.399]

Machovich R (2003) Disorders of the blood coagulation-fibrinolytic system. In Keri Gy, Toth I (eds) Molecular pathomechanism and new bends in drug research. Taylor and Francis Group, London and New York, pp 458-464... [Pg.506]

Gouzoulis- Mayfrank E, Hermle L, Thelen B et al (1998) History, rationale and potential human experimental hallucinogenic drug research in psychiatry. Pharmacopsychiatry (Suppl)31 63-68... [Pg.1046]

GB Herpetad (Boehringer Ing.) Dravyr (Drug Research) USA Zovirax (Glaxo Wellcome ... [Pg.33]

Emoflux (Metapharma) Flomed (Pulitzer) Flupress (Drug Research)... [Pg.286]

Isok (San Carlo) Ketartrium (Esseti) Ketodol (Drug Research) Ketofen (Delsaz Filippini as lysine salt) Meprofen (AGIPS) Orudis (Rhone-Poulenc Rorer)... [Pg.1126]

Adalat (Bayer Italia 1976) Anifed (Farmac. Formenti) Citilat (CD Coral (Drug Research) Nifedicor (Monsanto) Nifedin (Benedetti)... [Pg.1434]

L. B. Kier and C.-K. Cheng, A cellular automata model of partitioning between liquid phases. In Lipophilicity in Drug Research, Pliska, Testa, and Waterbeemd, eds., VCH Publ., 1996. [Pg.86]

Kier LB, Hall LH. Molecular connectivity in chemistry and drug research. New York Academic Press, 1976. [Pg.318]

Redshaw S. Angiotensin-converting enzyme (ACE) inhibitors and the design of captopril. In Ganellin CR, Roberts SM, editors. Medicinal chemistry. The role of organic chemistry in drug research, 2nd edition. Fondon Academic Press, 1993. p. 163-85. [Pg.413]

Farde, L (1996) The advantage of using positron emission tomography in drug research. Trends Neurosci. 19 211-214. [Pg.372]

EDWARDS s, KOCH G G, SOLLECITO w A, PEACE K E (1990) Siunmarizatiou, analysis, and monitoring of adverse experiences, in Statistical Issues in Drug Research and Development, New York, Marcel Dekker, Inc, 19-170. [Pg.251]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...